chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client received Hep. A. 12/3/07. On 12/4/07 child awakening out of a sleep at night, panicked short of breath and frantically running out of room. Every night since that time child has had these episodes at night. Mom stated she will breathe regularly then decrease then stop, then wake up in a panic. Child has been to ER - had chest x-ray which was WNL - Had another x-ray 12/10 which was neg, All blood work was neg. (per mom)
About 11 hours after receiving his MMR vaccine patient began to get very tiered, his lips turned blue and he was unresponsive for about 10 min, then he vomited but remained very flushed and unresponsive for another 10 min. The peramedics were called and had him go to our local ER.
Information has been received from a 78 year old male with blood pressure high, enlarged prostate and glaucoma who on 22-OCT-2007 was vaccinated with ZOSTAVAX. Concomitant vaccine therapy that day included influenza virus vaccine (unspecified) (manufacturer unknown). Concomitant therapy included AVODART, COSOPT and PRILOSEC. At the time of reporting, 29 OCT 2007, the patient was recovering, and due to be seen by his physician that same day. There was no product quality complaint. Follow up information was received from the consumer who reported that he was experiencing "violent diarrhea" for four weeks and is under the care of two physicians. The consumer noted he did not think that this was related to the vaccine. It was also reported that unspecified blood work and a stool test were obtained, of which the results were not provided. The consumer did not provide physician contact information. No further information is expected. Additional information has been requested.
pt said that she had sore swollen jaw and swollen arm that itched, she went to the er on 9/3 and the er told her to take benadryl and report the event to the pharmacy.
h/a last 1hr off & on;sick to stomach, diarrhea 1x/day x 10 days;vomiting x 1 on 1st day;little dizzy in AM then fine;
Patient received a second flu vaccine when he wanted a Covid booster vaccine. The first flu vaccine was administered 8/12/2023. The second flu vaccines was administered 10/15/2023. The patient was counseled and his primary care doctor was notified of the administration of an additional flu vaccines 2 months after the first. The patient received the Covid vaccines after discovery of the error.
Swelling at face and extremities; Swelling at face and extremities; All over the body is itchy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling at face and extremities), PERIPHERAL SWELLING (Swelling at face and extremities) and PRURITUS (All over the body is itchy) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 072A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced SWELLING FACE (Swelling at face and extremities), PERIPHERAL SWELLING (Swelling at face and extremities) and PRURITUS (All over the body is itchy). At the time of the report, SWELLING FACE (Swelling at face and extremities), PERIPHERAL SWELLING (Swelling at face and extremities) and PRURITUS (All over the body is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Fully vaccinated patient tested Covid positive 4/20/21 using PCR test through Lab.
May possibly have allergy; Tested positive for COVID/had trouble breathing/Developed pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 PNEUMONIA (Tested positive for COVID/had trouble breathing/Developed pneumonia) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, the patient experienced COVID-19 PNEUMONIA (Tested positive for COVID/had trouble breathing/Developed pneumonia) (seriousness criterion medically significant). On an unknown date, the patient experienced HYPERSENSITIVITY (May possibly have allergy). At the time of the report, COVID-19 PNEUMONIA (Tested positive for COVID/had trouble breathing/Developed pneumonia) and HYPERSENSITIVITY (May possibly have allergy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-May-2021, SARS-CoV-2 test: positive (Positive) developed pneumonia.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.   Treatment for the event included: Amoxicillin.  Company comment: Very limited information regarding this event of Hypersensivitiy has been provided at this time. Further information has been requested. Based on biological implausibility the event of COVID-19 infection causality is assessed as not applicable in related to mRNA-1273.; Sender's Comments: Very limited information regarding this event of Hypersensivitiy has been provided at this time. Further information has been requested. Based on biological implausibility the event of COVID-19 infection causality is assessed as not applicable in related to mRNA-1273.
dose given past the 12 hour post puncture time; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose given past the 12 hour post puncture time) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Sep-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose given past the 12 hour post puncture time). On 15-Sep-2021, EXPIRED PRODUCT ADMINISTERED (dose given past the 12 hour post puncture time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-328674, MOD-2021-328946, MOD-2021-327829, MOD-2021-327835, MOD-2021-327839, MOD-2021-327846, MOD-2021-328129, MOD-2021-328125.
only the liquid part of the vaccine was given and the powder portion was not mixed in with it with no reported adverse event; Initial information received on 13-Dec-2022 regarding an unsolicited valid  non-serious case via other health professional.  This case involves a 3-year-old male patient and the reporter reported only the liquid part of the vaccine was given and the powder portion was not mixed in with it with no reported adverse event after receiving diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (vero)].  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.  Concomitant medications included measles vaccine, mumps vaccine, rubella vaccine (MMR) for Prophylactic vaccination; and varicella zoster vaccine (Varicella Vaccine) for Prophylactic vaccination.  On 13-Dec-2022, the patient received 0.5 mL of suspect diphtheria/tetanus/5 HYBRID AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine (batch lot: UJ678AAA) (strength: unknown) (expiry date: 09-Sep-2023) via intramuscular route in unknown administration site for immunization.  On 13-Dec-2022 the patient had a non-serious event of only the liquid part of the vaccine was given and the powder portion was not mixed in with it with no reported adverse event (product preparation issue) (latency: same day) following the administration of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine.  Action taken with diphtheria, tetanus, AC pertussis, IPV AND HIB vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  Outcome: Unknown.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
mom was hold child to recv vax 30JAN97 & during the inj the hub of the needle got loose & the vax sprayed into mom's eyes;according to the nurse mom was not particularly close to the vax when it sprayed;later mom eyes began to sting;
Bilateral ringing in ears. Started 8 hours after 2nd dose of Covid Vaccine. Lasted 12 hours. No history of same. Reported as peer had similar side effects.  No dizziness
10/16/22 Employee called Employee Health hotline to report she had a silver dollar size rash to the side of her 10/14 flu  injection site and another one a few hows later below her injection site.  The next day she had a rash on her next. Rashes were raised small papiales that were itchy and warm to touch.  Employee states she took Benadryl.  She declines any SOB.  She has had many flu vaccine but never reacted this way before.  She did have a bad hive reaction to Varivax some years ago. The neck rash has resolved as of 10/16/22 but the arm rask is still present. She is followin up with Occupational Health provider on 10/17/22.
She got her vaccine, and also got the flu shot the same day as well, and wanted to give her the HPV vaccine as well, but mother said that the two were enough.  Mother then noticed that her face turned red and looked like her veins were move visible than normal in her neck and her heart was racing, and she was sweating.  Her mother told her to sit down and trying to get her mind off of it, and she told her mom not to leave her as she did not feel well.  She was short of breath, running a fever.  She was urinating a lot, was not eating much and not feeling well.  Then on 10/4/21 she went out at around 11:30 PM.   On 10/5/21 at 5:30 PM the police came to tell her that her daughter had died.  An autopsy was done, and the coroner informed her that she had cardiomegaly, pulmonary edema.  Mother was not aware that she had cardiomegaly.  Three weeks prior to that she was at the hospital as she was complaining of stomach pains and had gallstones.    She left the house with a cap over her head and apparently went to a location where there were a lot of people and had agonal breathing but nobody called for an ambulance.  When she was found dead rigor mortice had set in.  She had an EKG at that time and she was diagnosed with anything.  Her heart was 550 grams.  Was a very active girl who did not show any signs of problems.   She had been in the psychiatric unit a few times, possibly 30 times, and she was never diagnosed with any heart issues.    She also had a similar reaction with the first vaccine of the neck veins popping out, the redness of her face and did not feel well the entire month leading up to the 2nd vaccine.
Severe weakness unable to move arms and legs with confusion mental status changes and severe nausea vomiting  lightheadedness.
Pt c/o heart palpitations and "foggy brain" and feeling tired a few minutes after receiving vaccine.  All VS within normal limits, patient remained alert and oriented.  Medical Director contacted, but patient started feeling better and did not want to stay for evaluation.
Positive SARS-CoV-2; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.    On 08-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive SARS-CoV-2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Syncopal episode, evaluated by Dr. and EMS. Prior episodes at the gym, noted by patient. States no solid food for 16 hours prior, except for coffeeshop. Had worked the night shift during that time. Patient given apple juice and snack box. States he was feeling fine, and walked to the door escorted by EMS.
sickly; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "sickly". Additional information: Caller asked why Pfizer covid-19 vaccine was being recommended while people are dying and what was the content of the vaccine and her husband became sickly when he took the vaccine too.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Low grade fever (around 100°); Little bit of nausea; Fatigue; A spontaneous report was received from a caregiver on behalf of a patient concerning an 87-year-old male patient who experienced a little bit of nausea, fatigue and a low grade fever.   The patient's medical history was not provided. Concomitant product use was not provided by the reporter.     On 02 Jan 2021, approximately one day prior to the onset of the symptoms, the patient received their dose of mRNA-1273 (Batch number not provided) in the left arm for prophylaxis of COVID-19 infection.    A day after the vaccination shot, on 03 Jan 2021, the patient experienced a little bit of nausea and fatigue. The nausea subsided but the fatigue persisted. On 07 Jan 2021, he experienced a low-grade fever.  Treatment information was not provided/unknown.    Action taken with mRNA-1273 in response to the event(s) was not provided/unknown.  The event, [little bit of nausea], was considered recovered/resolved on 04 Jan 2021.   The outcome of the events, [fatigue and low-grade fever], were considered unknown.   Reporter causality for the events was not provided. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Little bit of nausea), FATIGUE (Fatigue) and PYREXIA (Low grade fever (around 100°)) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported).    On 02-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Jan-2021, the patient experienced NAUSEA (Little bit of nausea) and FATIGUE (Fatigue). On 07-Jan-2021, the patient experienced PYREXIA (Low grade fever (around 100°)). On 04-Jan-2021, NAUSEA (Little bit of nausea) had resolved. At the time of the report, FATIGUE (Fatigue) and PYREXIA (Low grade fever (around 100°)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Received Menactra on 8/23/06. On 8/24/06 had fever to 103, generalized achiness esp. in lower extremities, weak and wobbly. At 2AM 8/24 looked tired and sleepy, joint tenderness L deltoid. Observed and returned to usual self.
ED to Hosp-Admission Discharged   8/22/2021 - 8/24/2021 (2 days) Hospital   Last attending ? Treatment team 2019-nCoV acute respiratory disease  Principal problem shortness of breath.  Chief complaint: shortness of breath.   Patient is an 44 y.o. male with hx of morbid obesity, hypertension NSTEMI in 2019 with subsequent clean cardiac cath, OSA not presently treated who presents with progressive shortness of breath for the past few days. Loss of taste and smell. Subjective fevers with chills. URI symptoms. Pt had been fully vaccinated for COVID earlier this year. Actually had additional vaccine on 8/18. Pt states he was exposed to COVID recently.
Headache; neck/shoulder tightening; slight eye focus; dizziness; chills; body aches; fever highest 99.4; sweating/claminess; sweating/claminess; shoulder tightening; This is a spontaneous report from a contactable consumer (patient). A 54-year-old non pregnant female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), via an unspecified route of administration, administered in left arm on 14Jun2021 at 11:30 (at the age of 54-year-old) (Batch/Lot Number: EW0168) as dose 1, single for covid-19 immunisation. Medical history included Charcoe Marie Tooth and Heart Disease-Stent. Concomitant medications included acetylsalicylic acid (ASPIRIN LOW) and Melatonin. The patient previously experienced known allergies for Bactroban [mupirocin], Minocycline and Penicillin. It was reported that patient experienced covid prior to vaccination. On 15Jun2021 the patient experienced headache, neck/shoulder tightening, slight eye focus, dizziness, chills, body aches, fever highest 99.4 and sweating/clamminess. Patient did not receive any other vaccines within 4 weeks to the COVID vaccine. The patient had not been tested post vaccination for Covid. Patient did not receive treatment for events. The patient underwent lab tests and procedures which included pyrexia: highest 99.4 on 15Jun2021. Outcome of all the events recovered on unspecified date in 2021.  Follow-up attempts are completed. No further information is expected.
Hot felling at base of neck; This spontaneous case was reported by a patient family member or friend and describes the occurrence of FEELING HOT (Hot felling at base of neck) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091021A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Hot felling at base of neck). At the time of the report, FEELING HOT (Hot felling at base of neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Caller states she woke up, feeling like she had a hangover, dehydrated with a blistering headache, after the first vaccine.; Caller states she woke up, feeling like she had a hangover, dehydrated with a blistering headache, after the first vaccine.; Caller states she woke up, feeling like she had a hangover, dehydrated with a blistering headache, after the first vaccine.; This is a spontaneous report from a contactable consumer (patient). A 28-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8733) via an unspecified route of administration, administered in Arm Right on 01Apr2021 at 09:00 as a single dose for covid-19 immunisation. Medical history included overweight from 1993 to 2010, Childhood history of asthma (she was diagnosed sometime in middle school and had an inhaler for a couple years. Reclarified, Caller did not use the inhaler in college or after that time), hormone therapy. Concomitant medication included estradiol cipionate (DEPO-ESTRADIOL) taken for hormone therapy from Aug2019 and ongoing (1.5 cc every other week, injection), PROGESTERON taken for hormone therapy from 15Apr2019 and ongoing via oral (200 mg, daily). Historical vaccine information included Flu shot on unspecified date and experienced she got sick for the first couple of years. Caller reports that she would get mildly sick, for a day or two and this included feeling like she had a cold, chills, and was achy. Caller states it started, in the eighth grade, around 2007. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 02Apr2021 at 14:30, the patient states she woke up, feeling like she had a hangover, dehydrated with a blistering headache, after the first vaccine . Caller stated a few hours later, around 05:30 pm, she felt fine. On 02Apr2021 at 17:30, the outcome for event was recovered
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The nurse reported that on an unknown date in 2014 an unspecified number of patients were vaccinated with PNEUMOVAX 23 (dose, route, lot number and expiration date were not provided) which was exposed to 34F for 30 minutes. No adverse event was observed or reported. Additional information has been requested.
Pt reported rapid heart beat. presented to MD office, where he was told he had Atrial Fibrillation which was likely precipitated due to the Fluzone HD vaccine given the day before. He then came to pharmacy to report the reaction to the pharmacist. He is under care of his physician for the AFib.
Day after i developed a sharp  fleeting pain in upper left abd  area right under ribs. pain subsided yet since that day this pain contineus. not a sharp . just constant.